Back
US Physical Therapy Vs. Monopar Therapeutics Industry Stock Comparison
Sell
45
USPH
US Physical Therapy
Last Price:
$71.90
Seasonality Move:
11.7%
Sell
48
MNPR
Monopar Therapeutics
Last Price:
$41.84
Seasonality Move:
-14.17%
Sell
45
US Physical Therapy (USPH)
is a Sell
Is US Physical Therapy a Buy, Sell or Hold?
-
The current US Physical Therapy [USPH] share price is $71.93. The Score for USPH is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
USPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $40.33. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
USPH Stock Price Chart
What is US Physical Therapy's stock price today?
-
The US Physical Therapy share price today is $71.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and USPH is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $40.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
USPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.34 | Sell |
| Relative Strength Index (14 RSI): | 24.91 | Sell |
| Chaikin Money Flow: | -28963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.91 - 83.29) | Sell |
| Bollinger Bands (100): | (80.88 - 94.88) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 56.65 | Buy |
| Chaikin Money Flow: | 2380 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.07 - 39.49) | Buy |
| Bollinger Bands (100): | (19.65 - 39.65) | Buy |
USPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.54 | Sell |
| 20-day SMA: | 76.82 | Sell |
| 50-day SMA: | 83.55 | Sell |
| 200-day SMA: | 88.06 | Sell |
| 8-day EMA: | 73.69 | Sell |
| 20-day EMA: | 76.78 | Sell |
| 50-day EMA: | 81.69 | Sell |
| 200-day EMA: | 88.27 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.86 | Buy |
| 20-day SMA: | 34.79 | Buy |
| 50-day SMA: | 37.86 | Buy |
| 200-day SMA: | 17.05 | Buy |
| 8-day EMA: | 38.75 | Buy |
| 20-day EMA: | 37.13 | Buy |
| 50-day EMA: | 35.15 | Buy |
| 200-day EMA: | 21.74 | Buy |
US Physical Therapy Earnings Growth & USPH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.01 per share, and an increase next year of $0.28 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
US Physical Therapy Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||